> top > docs > PMC:7205724 > spans > 39-208 > annotations

PMC:7205724 / 39-208 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 93-108 Body_part denotes immunoglobulins http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 50-74 Chemical denotes immunosuppressive agents http://purl.obolibrary.org/obo/CHEBI_35705
T2 114-129 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T1 93-108 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes immunoglobulins http://purl.bioontology.org/ontology/MEDDRA/10021496

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T1 50-67 http://purl.obolibrary.org/obo/IDO_0000610 denotes immunosuppressive

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 114-129 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T2 1-75 Sentence denotes Rationale and hypothesis for the use of multiple immunosuppressive agents:
T3 76-129 Sentence denotes Anti-antibodies, immunoglobulins, and corticosteroids
T4 131-141 Sentence denotes Highlights

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T6 1-10 NN denotes Rationale
T7 11-14 CC denotes and
T8 15-25 NN denotes hypothesis
T9 26-29 IN denotes for
T10 30-33 DT denotes the
T11 34-37 NN denotes use
T12 38-40 IN denotes of
T13 41-49 JJ denotes multiple
T14 50-67 JJ denotes immunosuppressive
T15 68-74 NNS denotes agents
T16 74-75 -COLON- denotes :
T17 76-91 NNS denotes Anti-antibodies
T18 91-92 -COMMA- denotes ,
T19 93-108 NNS denotes immunoglobulins
T20 108-109 -COMMA- denotes ,
T21 110-113 CC denotes and
T22 114-129 NNS denotes corticosteroids
T23 131-141 NNS denotes Highlights
T24 142-143 IN denotes •
T25 145-149 NNP denotes IVIG
T26 149-150 -COMMA- denotes ,
T27 151-159 VBN denotes combined
T28 160-164 IN denotes with
R5 T6 T7 arg1Of Rationale,and
R6 T8 T7 arg2Of hypothesis,and
R7 T7 T9 arg1Of and,for
R8 T11 T9 arg2Of use,for
R9 T11 T10 arg1Of use,the
R10 T11 T12 arg1Of use,of
R11 T15 T12 arg2Of agents,of
R12 T15 T13 arg1Of agents,multiple
R13 T15 T14 arg1Of agents,immunosuppressive
R14 T7 T16 arg1Of and,:
R15 T17 T18 arg1Of Anti-antibodies,","
R16 T19 T18 arg2Of immunoglobulins,","
R17 T21 T20 arg1Of and,","
R18 T18 T21 arg1Of ",",and
R19 T22 T21 arg2Of corticosteroids,and
R20 T25 T24 arg1Of IVIG,•
R21 T25 T26 arg1Of IVIG,","
R22 T25 T27 arg2Of IVIG,combined
R23 T27 T28 arg1Of combined,with

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T1 93-108 Body_part denotes immunoglobulins http://purl.org/sig/ont/fma/fma62871

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T2 1-75 Sentence denotes Rationale and hypothesis for the use of multiple immunosuppressive agents:
T3 76-129 Sentence denotes Anti-antibodies, immunoglobulins, and corticosteroids
T4 131-141 Sentence denotes Highlights